Quinn William P.'s Form 4 filing
Bolt Biotherapeutics, Inc. (BOLT) · filed Dec 13, 2023
- Accession no.
- 0001209191-23-058458
- Filed
- Dec 13, 2023
- Trade date
- Jun 6-Dec 12, 2023
- Filing delay
- 190 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $11.2K. It was filed 190 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Quinn William P.CIK 0001724190 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2023 | Common Stock | PPurchaseAcquired | +1,829 | $1.18 | +$2,158.22 | 26,272 | Direct | |
| Dec 6, 2023 | Common Stock | PPurchaseAcquired | +2,500 | $0.78 | +$1,950 | 28,772 | Direct | |
| Dec 12, 2023 | Common Stock | PPurchaseAcquired | +7,500 | $0.95 | +$7,125 | 36,272 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.